South Korea Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

South Korea Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0248DB
  • |
  • Pages: 110
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

South Korea Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "South Korea Drug Delivery Devices Market Outlook to 2023", provides key market data on the South Korea Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the South Korea Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Drug Delivery Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Drug Delivery Devices Market, South Korea 11

3.1 Drug Delivery Devices Market, South Korea, Revenue ($m), 2009-2023 11

3.2 Drug Delivery Devices Market, South Korea, Revenue Mix ($m), 2016 13

3.3 Drug Delivery Devices Market, South Korea, Category Contribution by Revenue ($m), 2016 14

3.4 Drug Delivery Devices Market, South Korea, Category Comparison by Revenue ($m), 2009-2023 15

3.5 Drug Delivery Devices Market, South Korea, Revenue ($m), 2009-2016 17

3.6 Drug Delivery Devices Market, South Korea, Revenue ($m), 2016-2023 19

3.7 Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2023 21

3.8 Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2016 23

3.9 Drug Delivery Devices Market, South Korea, Volume (Units), 2016-2023 25

3.10 Drug Delivery Devices Market, South Korea, Company Share by Revenue ($m), 2016 27

4 Central Venous Catheters Market, South Korea 29

4.1 Central Venous Catheters Market, South Korea, Revenue Mix ($m), 2016 29

4.2 Central Venous Catheters Market, South Korea, Segment Contribution (%), 2016 30

4.3 Central Venous Catheters Market, South Korea, Revenue ($m), 2009-2016 31

4.4 Central Venous Catheters Market, South Korea, Revenue ($m), 2016-2023 33

4.5 Central Venous Catheters Market, South Korea, Volume (Units), 2009-2016 35

4.6 Central Venous Catheters Market, South Korea, Volume (Units), 2016-2023 37

4.7 Central Venous Catheters Market, South Korea, Distribution Share by Revenue ($m), 2015-2016 39

4.8 Central Venous Catheters Market, South Korea, Company Share by Revenue ($m), 2016 40

5 Infusion Systems Market, South Korea 42

5.1 Infusion Systems Market, South Korea, Revenue Mix ($m), 2016 42

5.2 Infusion Systems Market, South Korea, Segment Contribution (%), 2016 43

5.3 Infusion Systems Market, South Korea, Revenue ($m), 2009-2016 45

5.4 Infusion Systems Market, South Korea, Revenue ($m), 2016-2023 47

5.4.1 Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), by Segment, 2009-2016 49

5.4.2 Syringe Pumps Market, South Korea, Revenue ($m), by Segment, 2009-2016 51

5.4.3 Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), by Segment, 2016-2023 53

5.4.4 Syringe Pumps Market, South Korea, Revenue ($m), by Segment, 2016-2023 55

5.5 Infusion Systems Market, South Korea, Volume (Units), 2009-2016 57

5.6 Infusion Systems Market, South Korea, Volume (Units), 2016-2023 59

5.6.1 Ambulatory Infusion Pumps Market, South Korea, Volume (Units), by Segment, 2009-2016 61

5.6.2 Syringe Pumps Market, South Korea, Volume (Units), by Segment, 2009-2016 63

5.6.3 Ambulatory Infusion Pumps Market, South Korea, Volume (Units), by Segment, 2016-2023 65

5.6.4 Syringe Pumps Market, South Korea, Volume (Units), by Segment, 2016-2023 67

5.7 Infusion Systems Market, South Korea, Distribution Share by Revenue ($m), 2015-2016 69

5.8 Infusion Systems Market, South Korea, Company Share by Revenue ($m), 2016 70

6 Infusion Systems Market, South Korea 72

6.1 Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), 2009-2016 72

6.2 Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), 2016-2023 73

6.3 Metered Dose Inhaler Devices Market, South Korea, Volume (Units), 2009-2016 74

6.4 Metered Dose Inhaler Devices Market, South Korea, Volume (Units), 2016-2023 75

6.5 Metered Dose Inhaler Devices Market, South Korea, Distribution Share by Revenue ($m), 2015-2016 76

6.6 Metered Dose Inhaler Devices Market, South Korea, Company Share by Revenue ($m), 2016 77

7 Needle Free Injections Market, South Korea 79

7.1 Needle Free Injections Market, South Korea, Revenue ($m), 2009-2016 79

7.2 Needle Free Injections Market, South Korea, Revenue ($m), 2016-2023 80

7.3 Needle Free Injections Market, South Korea, Volume (Units), 2009-2016 81

7.4 Needle Free Injections Market, South Korea, Volume (Units), 2016-2023 82

7.5 Needle Free Injections Market, South Korea, Distribution Share by Revenue ($m), 2015-2016 83

7.6 Needle Free Injections Market, South Korea, Company Share by Revenue ($m), 2016 84

8 Overview of Key Companies in South Korea, Drug Delivery Devices Market 86

8.1 GlaxoSmithKline Plc 86

8.1.1 Company Overview 86

8.2 Teleflex Inc 86

8.2.1 Company Overview 86

8.3 Edwards Lifesciences Corp 86

8.3.1 Company Overview 86

8.4 AstraZeneca Plc 86

8.4.1 Company Overview 86

8.5 Fresenius Kabi AG 87

8.5.1 Company Overview 87

8.6 Boehringer Ingelheim GmbH 87

8.6.1 Company Overview 87

8.7 Pfizer Inc 87

8.7.1 Company Overview 87

8.8 Baxter International Inc 88

8.8.1 Company Overview 88

8.9 Smiths Medical 88

8.9.1 Company Overview 88

8.10 Becton Dickinson and Co 88

8.10.1 Company Overview 88

8.11 Merck & Co Inc 89

8.11.1 Company Overview 89

8.12 Terumo Corp 89

8.12.1 Company Overview 89

8.13 B. Braun Melsungen AG 89

8.13.1 Company Overview 89

8.14 Hospira Inc 89

8.14.1 Company Overview 89

8.15 JMS Co Ltd 90

8.15.1 Company Overview 90

8.16 Medtronic plc 90

8.16.1 Company Overview 90

8.17 Nipro Corp 90

8.17.1 Company Overview 90

9 Drug Delivery Devices Market Pipeline Products 91

10 Financial Deals Landscape 96

10.1 Asset Transactions 96

10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 96

10.2 Equity Offerings 98

10.2.1 Curexo to Raise USD9.7 Million in Private Placement of Shares 98

10.2.2 BCWorld Pharm Raises USD1.8 Million in Private Placement of Shares 99

10.3 Partnerships 100

10.3.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 100

10.3.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 101

10.3.3 Pfizer Terminates its Licensing Agreement with pSivida 103

10.3.4 Bayer Enters into Licensing Agreement with DelSiTech 104

10.3.5 BioCorRx Enters into Licensing Agreement with Therakine 105

11 Appendix 106

11.1 Research Methodology 107

11.1.1 Coverage 107

11.1.2 Secondary Research 107

11.1.3 Primary Research 108

11.1.4 Company Share Analysis 108

11.1.5 Distribution Share Analysis 108

11.1.6 Benchmarking 109

11.2 GlobalData Consulting 109

11.3 Contact Us 110

11.4 Disclaimer 110

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, 2009-2023 11

Figure 2: Drug Delivery Devices Market, South Korea, Revenue Mix ($m), 2016 13

Figure 3: Drug Delivery Devices Market, South Korea, Category Contribution (%), 2016 14

Figure 4: Drug Delivery Devices Market, South Korea, Category Comparison by Revenue ($m), 2009-2023 15

Figure 5: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 6: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Figure 7: Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2023 21

Figure 8: Drug Delivery Devices Market, South Korea, Volume (Units), Historic, 2009-2016 23

Figure 9: Drug Delivery Devices Market, South Korea, Volume (Units), Forecast, 2016-2023 25

Figure 10: Drug Delivery Devices Market, South Korea, Company Share (%) 2016 27

Figure 11: Central Venous Catheters Market, South Korea, Revenue Mix ($m), 2016 29

Figure 12: Central Venous Catheters Market, South Korea, Segment Contribution (%), 2016 30

Figure 13: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 31

Figure 14: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Figure 15: Central Venous Catheters Market, South Korea, Volume (Units), Historic, 2009-2016 35

Figure 16: Central Venous Catheters Market, South Korea, Volume (Units), Forecast, 2016-2023 37

Figure 17: Central Venous Catheters Market, South Korea, Company Share (%) 2016 40

Figure 18: Infusion Systems Market, South Korea, Revenue Mix ($m), 2016 42

Figure 19: Infusion Systems Market, South Korea, Segment Contribution (%), 2016 43

Figure 20: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 45

Figure 21: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Figure 22: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 23: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 51

Figure 24: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 25: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Figure 26: Infusion Systems Market, South Korea, Volume (Units), Historic, 2009-2016 57

Figure 27: Infusion Systems Market, South Korea, Volume (Units), Forecast, 2016-2023 59

Figure 28: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Historic, 2009-2016 61

Figure 29: Syringe Pumps Market, South Korea, Volume (Units), Historic, 2009-2016 63

Figure 30: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023 65

Figure 31: Syringe Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023 67

Figure 32: Infusion Systems Market, South Korea, Company Share (%) 2016 70

Figure 33: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 72

Figure 34: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Figure 35: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Historic, 2009-2016 74

Figure 36: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Forecast, 2016-2023 75

Figure 37: Metered Dose Inhaler Devices Market, South Korea, Company Share (%) 2016 77

Figure 38: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 79

Figure 39: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Figure 40: Needle Free Injections Market, South Korea, Volume (Units), Historic, 2009-2016 81

Figure 41: Needle Free Injections Market, South Korea, Volume (Units), Forecast, 2016-2023 82

Figure 42: Needle Free Injections Market, South Korea, Company Share (%) 2016 84

1.1 List of Tables

Table 1: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, 2009-2023 12

Table 2: Drug Delivery Devices Market, South Korea, Category Contribution by Revenue ($m), 2016 14

Table 3: Drug Delivery Devices Market, South Korea, Category Comparison by Revenue ($m), 2009-2023 16

Table 4: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 18

Table 5: Drug Delivery Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Table 6: Drug Delivery Devices Market, South Korea, Volume (Units), 2009-2023 22

Table 7: Drug Delivery Devices Market, South Korea, Volume (Units), Historic, 2009-2016 24

Table 8: Drug Delivery Devices Market, South Korea, Volume (Units), Forecast, 2016-2023 26

Table 9: Drug Delivery Devices Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016 28

Table 10: Central Venous Catheters Market, South Korea, Segment Contribution (%), 2016 30

Table 11: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 32

Table 12: Central Venous Catheters Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 13: Central Venous Catheters Market, South Korea, Volume (Units), Historic, 2009-2016 36

Table 14: Central Venous Catheters Market, South Korea, Volume (Units), Forecast, 2016-2023 38

Table 15: Central Venous Catheters Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 16: Central Venous Catheters Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016 41

Table 17: Infusion Systems Market, South Korea, Segment Contribution (%), 2016 44

Table 18: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 46

Table 19: Infusion Systems Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Table 20: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 21: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 52

Table 22: Ambulatory Infusion Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 23: Syringe Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 56

Table 24: Infusion Systems Market, South Korea, Volume (Units), Historic, 2009-2016 58

Table 25: Infusion Systems Market, South Korea, Volume (Units), Forecast, 2016-2023 60

Table 26: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Historic, 2009-2016 62

Table 27: Syringe Pumps Market, South Korea, Volume (Units), Historic, 2009-2016 64

Table 28: Ambulatory Infusion Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023 66

Table 29: Syringe Pumps Market, South Korea, Volume (Units), Forecast, 2016-2023 68

Table 30: Infusion Systems Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69

Table 31: Infusion Systems Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016 71

Table 32: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 72

Table 33: Metered Dose Inhaler Devices Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Table 34: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Historic, 2009-2016 74

Table 35: Metered Dose Inhaler Devices Market, South Korea, Volume (Units), Forecast, 2016-2023 75

Table 36: Metered Dose Inhaler Devices Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016 76

Table 37: Metered Dose Inhaler Devices Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016 78

Table 38: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Historic, 2009-2016 79

Table 39: Needle Free Injections Market, South Korea, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Table 40: Needle Free Injections Market, South Korea, Volume (Units), Historic, 2009-2016 81

Table 41: Needle Free Injections Market, South Korea, Volume (Units), Forecast, 2016-2023 82

Table 42: Needle Free Injections Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2015-2016 83

Table 43: Needle Free Injections Market, South Korea, Company Share by Revenue ($m), USD Constant, 2016 85

Table 44: Drug Delivery Devices Market Pipeline Products 91

Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 96

Table 46: Curexo to Raise USD9.7 Million in Private Placement of Shares 98

Table 47: BCWorld Pharm Raises USD1.8 Million in Private Placement of Shares 99

Table 48: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 100

Table 49: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 101

Table 50: Pfizer Terminates its Licensing Agreement with pSivida 103

Table 51: Bayer Enters into Licensing Agreement with DelSiTech 104

Table 52: BioCorRx Enters into Licensing Agreement with Therakine 105

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

GlaxoSmithKline Plc

Teleflex Inc

Edwards Lifesciences Corp

AstraZeneca Plc

Fresenius Kabi AG

Boehringer Ingelheim GmbH

Pfizer Inc

Baxter International Inc

Smiths Medical

Becton Dickinson and Co

Merck & Co Inc

Terumo Corp

B. Braun Melsungen AG

Hospira Inc

JMS Co Ltd

Medtronic plc

Nipro Corp

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 430921
Site License
USD 11990 INR 861841
Corporate User License
USD 17985 INR 1292762

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com